- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Bellerophon Therapeutics is a biotechnology business based in the US. Bellerophon Therapeutics shares (BLPH) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.04 – the same closing value as a week prior. Bellerophon Therapeutics employs 18 staff and has a trailing 12-month revenue of around $5.6 million.
What's in this guide?
Our top picks for where to buy Bellerophon Therapeutics stock
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Complimentary access to a financial planner
- Trade $0 commission stocks, ETFs, and options with as little as $1
- After-hours trading available
- Earn 4.5% interest on uninvested cash with Gold
- 24/7 customer support
How to buy Bellerophon Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BLPH. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Bellerophon Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Bellerophon Therapeutics stock price (PINK: BLPH)
Use our graph to track the performance of BLPH stocks over time.Bellerophon Therapeutics shares at a glance
Latest market close | $0.04 |
---|---|
52-week range | $0.03 - $0.08 |
50-day moving average | $0.04 |
200-day moving average | $0.05 |
Wall St. target price | $2.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.89 |
Bellerophon Therapeutics price performance over time
Historical closes compared with the close of $0.04 from 2024-12-05
1 week (2024-11-29) | 0.04 |
---|---|
1 month (2024-11-07) | 8.11% |
3 months (2024-09-06) | 14.29% |
6 months (2024-06-07) | -46.60% |
1 year (2023-12-07) | 10.50% |
---|---|
2 years (2022-12-07) | -95.88% |
3 years (2021-12-07) | 2.57 |
5 years (2019-12-06) | 6.2265 |
Bellerophon Therapeutics financials
Revenue TTM | $5.6 million |
---|---|
Gross profit TTM | $0 |
Return on assets TTM | -78.47% |
Return on equity TTM | -165.96% |
Profit margin | -164.06% |
Book value | $0.30 |
Market Capitalization | $489,304 |
TTM: trailing 12 months
Bellerophon Therapeutics share dividends
We're not expecting Bellerophon Therapeutics to pay a dividend over the next 12 months.
Have Bellerophon Therapeutics's shares ever split?
Bellerophon Therapeutics's shares were split on a 1:15 basis on 9 February 2020 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bellerophon Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Bellerophon Therapeutics shares which in turn could have impacted Bellerophon Therapeutics's share price.
Bellerophon Therapeutics share price volatility
Over the last 12 months, Bellerophon Therapeutics's shares have ranged in value from as little as $0.03 up to $0.0785. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Bellerophon Therapeutics's is 0.704. This would suggest that Bellerophon Therapeutics's shares are less volatile than average (for this exchange).
Bellerophon Therapeutics overview
Bellerophon Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse, which is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc.
Frequently asked questions
nullWhat percentage of Bellerophon Therapeutics is owned by insiders or institutions?
Currently 15.027% of Bellerophon Therapeutics shares are held by insiders and 8.394% by institutions. How many people work for Bellerophon Therapeutics?
Latest data suggests 18 work at Bellerophon Therapeutics. When does the fiscal year end for Bellerophon Therapeutics?
Bellerophon Therapeutics's fiscal year ends in December. Where is Bellerophon Therapeutics based?
Bellerophon Therapeutics's address is: 20 Independence Boulevard, Warren, NJ, United States, 07059 What is Bellerophon Therapeutics's ISIN number?
Bellerophon Therapeutics's international securities identification number is: US0787713009 What is Bellerophon Therapeutics's CUSIP number?
Bellerophon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 078771300
More guides on Finder
-
Best Paper Trading Apps to Practice Trading With Fake Money in 2024
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
-
5 Best International Stock Brokers to Invest in Foreign Assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
9 Best Robo-Advisors for Automatic Investing
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Betterment alternatives
5 Betterment robo-advisor alternatives to consider when building your portfolio.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to gift stock
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
Acorns review 2024
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.
Ask a question